 
| IPAD-DB ID | S00112 | 
| Name | 29-N-Demethylparaherquamide | 
| Category | Synthetic compounds | 
| 2D Structure |  | 
| 3D Structure | |
| Molecular Formula | C 2 7 H 3 1 N 3 O 5 | 
| Molecular Weight | 477.6g/mol | 
| IUPAC Name | (1'S, 5'R, 7'R, 8R, 9'S)-4, 4, 5', 10', 10'-pentamethylspiro[10H-[1, 4]dioxepino[2, 3-g]indole-8, 11'-3, 13-diazatetracyclo[5.5.2.01, 9.03, 7]tetradecane]-4', 9, 14'-trione | 
| InChI | InChI=1S/C27H31N3O5/c1-14-10-26-11-17-24(4, 5)27(12-25(17, 29-21(26)32)13-30(26)20(14)31)15-6-7-16-19(18(15)28-22(27)33)34-9-8-23(2, 3)35-16/h6-9, 14, 17H, 10-13H2, 1-5H3, (H, 28, 33)(H, 29, 32)/t14-, 17+, 25-, 26+, 27-/m1/s1 | 
| InChIKey | PEVZJUJQPWJAGG-PVKOJMPMSA-N | 
| Canonical SMILES | CC1CC23CC4C(C5(CC4(CN2C1=O)NC3=O)C6=C(C7=C(C=C6)OC(C=CO7)(C)C)NC5=O)(C)C | 
| PubChem CID | 127037726 | 
| DrugBank Accession Number | - | 
| CAS Registry Number | - | 
| Molecular Weight(Computed by SwissADME) | 477.55 | 
| Hac(Computed by SwissADME) | 35 | 
| Volume(Computed by ADMETlab 2.0) | 474.139 | 
| Density(Computed by ADMETlab 2.0) | 1.007 | 
| nRing(Computed by ADMETlab 2.0) | 8 | 
| MaxRing(Computed by ADMETlab 2.0) | 14 | 
| nHet(Computed by ADMETlab 2.0) | 8 | 
| fChar(Computed by ADMETlab 2.0) | 0 | 
| nRig(Computed by ADMETlab 2.0) | 36 | 
| Flexibility(Computed by ADMETlab 2.0) | 0 | 
| Stero Centers(Computed by ADMETlab 2.0) | 6 | 
| LogS(Computed by ADMETlab 2.0) | -4.653 | 
| LogD(Computed by ADMETlab 2.0) | 3.345 | 
| logP(Computed by ADMETlab 2.0) | 3.403 | 
| TPSA(Computed by SwissADME) | 96.97 | 
| Hbond Acceptor(Computed by SwissADME) | 5 | 
| Hbond Donor(Computed by SwissADME) | 2 | 
| Rotatable Bonds(Computed by SwissADME) | 0 | 
| GI Absorption(Computed by SwissADME) | High | 
| BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No | 
| P-gp Substrate(Computed by SwissADME) | Yes | 
| CYP1A2 Inhibitor(Computed by SwissADME) | No | 
| CYP2C19 Inhibitor(Computed by SwissADME) | No | 
| CYP2C9 Inhibitor(Computed by SwissADME) | No | 
| CYP2D6 Inhibitor(Computed by SwissADME) | No | 
| CYP3A4 Inhibitor(Computed by SwissADME) | Yes | 
| log Kp(Skin Permeation)(Computed by SwissADME) | -7.89 | 
| Lipinski(Computed by SwissADME) | 0 | 
| Ghose(Computed by SwissADME) | 1 | 
| Veber(Computed by SwissADME) | 0 | 
| Egan(Computed by SwissADME) | 0 | 
| Muegge(Computed by SwissADME) | 0 | 
| Bioavailability Score(Computed by SwissADME) | 0.55 |